Editas Medicine Stock Performance
as on November 3, 2026 at 7:59 am IST
Day's Low
Day's High
$2.55$2.77
0.39%
Downside
8.20%
Upside
52 Week's Low
52 Week's High
$1.66$3.9435.16%
Downside
53.91%
Upside
Editas Medicine share price movements today
- Previous Close
- $2.67
- Open
- $2.70
- Volume
- 1.0M
- Market Cap
- $453.1M
- Day's Low - High
- $2.55 - $2.77
- 52 Week Low - High
- $1.66 - $3.94
Editas Medicine Historical Returns
- 1 Month Return
- + 14.01 %
- 3 Month Return
- + 8.92 %
- 1 Year Return
- -2.66 %
- 3 Year Return
- -53.71 %
- 5 Year Return
- -92.02 %
Editas Medicine Stock Fundamentals & Key Indicators
Check Editas Medicine market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$453.1M
EPS (TTM)
-0.7478
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.94
Industry PE ratio
-7.60
PEG Ratio
-0.02
EBITDA
-70.2M
Revenue (TTM)
47.0M
Profit Margin
56.90%
Return On Equity TTM
-196.63%
Editas Medicine vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Editas Medicine with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $453.1M | -92.02% | -3.94 | 56.90% | 0.00% | |
| Neutral | $88.5B | -36.40% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 208.09% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 45.26% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Editas Medicine Stock including INR - Dollar returns
The Editas Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Editas Medicine investment value today
Current value as on today
₹90,971
Returns
Returns from Editas Medicine Stock
Dollar Impact
₹5,921 (+5.92%)
Analyst Recommendation on Editas Medicine Stock
Based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Editas Medicine. Average target price of $6.1
Editas Medicine Share Price Target
Get share price movements and forecasts by analysts on Editas Medicine.
What analysts predicted
58.03%UPSIDE
Target Price
$6.1
Current Price
$2.56
Analyzed by
5 Analysts
High
$8
Target
$6.10
Low
$5
Editas Medicine target price $6.1, a slight upside of 58.03% compared to current price of $2.56. According to 5 analysts rating.
Indian Investors' Interest in Editas Medicine Stock
Search interest for Editas Medicine Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:54% versus previous 30 day period
Editas Medicine Quarterly Profit & Loss
All numbers in Millions USD
Editas Medicine Annual Profit & Loss
All numbers in Millions USD
Editas Medicine Quarterly Cash Flow
All numbers in Millions USD
Editas Medicine Annual Cash Flow
All numbers in Millions USD
Editas Medicine News & Key Events
Today's Timeline - 08 October
Thu, 04:36 PM
-Editas Medicine receives approval to initiate Phase 1/2 Strive trial of EDIT-401 in Australia for familial hypercholesterolemia.
Insights on Editas Medicine
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 2.83M → 11.88M (in $), with an average increase of 76.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, EDIT stock has moved up by 2.7%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -24.98M → -18.23M (in $), with an average increase of 37.0% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 186.0% return, outperforming this stock by 253.9%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 790.1% return, outperforming this stock by 802.8%
About Editas Medicine
| Organisation | Editas Medicine |
| Headquarters | 11 Hurley Street, Cambridge, MA, 02141, US |
| Industry | Biotechnology |
| CEO | Gilmore O'Neill |
Key Management of Editas Medicine
Name | Title |
|---|---|
Ms. Amy Parison | Senior VP & CFO |
Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
Mr. Tom Love | Vice President of People |
Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Dr. Gilmore O'Neill M.D. | President, CEO & Director |
Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Frank Panaccio | Senior VP & Chief Business Officer |
FAQs
What is Editas Medicine share price today?
Editas Medicine share price today is $2.56 as on at the close of the market. Editas Medicine share today touched a day high of $2.77 and a low of $2.55.
What is the 52 week high and 52 week low for Editas Medicine share?
Editas Medicine share touched a 52 week high of $3.94 on and a 52 week low of $1.66 on . Editas Medicine stock price today i.e. is closed at $2.56,which is 35.03% down from its 52 week high and 54.22% up from its 52 week low.
What is Editas Medicine's market capitalisation today?
Editas Medicine market capitalisation is $0.00T as on .
How to invest in Editas Medicine Stock (EDIT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Editas Medicine on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Editas Medicine Stock (EDIT) from India?
Indian investors can start investing in Editas Medicine (EDIT) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Editas Medicine stock (as per the Rupee-Dollar exchange rate as on ).
Based on Editas Medicine share’s latest price of $2.56 as on November 3, 2026 at 2:29 am IST, you will get 3.9063 shares of Editas Medicine. Learn more about
fractional shares .
What are the returns that Editas Medicine has given to Indian investors in the last 5 years?
Editas Medicine stock has given -92.02% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?